Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study | Zendy

XiHsuan Lin | Zendy; Shih-Hao Young | Zendy; JiingChyuan Luo | Zendy; YenLing Peng | Zendy; PingHsien Chen | Zendy; ChungChi Lin | Zendy; WeiMing Chen | Zendy; MingChih Hou | Zendy; FaYauh Lee | Zendy

Open Access

Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study

Author(s) -

XiHsuan Lin,

Shih-Hao Young,

JiingChyuan Luo,

YenLing Peng,

PingHsien Chen,

ChungChi Lin,

WeiMing Chen,

MingChih Hou,

FaYauh Lee

Publication year - 2017

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnx097

Subject(s) - medicine , proportional hazards model , cohort study , cohort , upper gastrointestinal bleeding , population , emergency medicine , environmental health , endoscopy

Cyclooxygenase-2 inhibitors (coxibs) are associated with less upper gastrointestinal bleeding (UGIB) than traditional nonsteroidal anti-inflammatory drugs (tNSAIDs). However, they also increase the risk of UGIB in high-risk patients. We aimed to identify the risk factors of UGIB in coxibs users.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research